MindImmune Therapeutics, Inc.

Amendment
CIK: 0001792522·Pharmaceuticals·DELAWARE·Filed: Mar 5, 2026
Total Offering

$17,014,485

Amount Sold

$15,218,343

Investors

15

First Sale

Nov 24, 2025

Offering Details

Type
Equity, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Isaac Stoner
Related Person
Bradley Margus
Related Person
Christopher O'Donnell
Related Person
Reetika Bhardwaj
Related Person

Company

MindImmune Therapeutics, Inc.

130 FLAGG ROAD

KINGSTON, RI, 02881

401-225-4612

SEC Filing

0001792522-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
MindImmune Therapeutics, Inc. Form D Filing — $17,014,485 | FilingFlow